Hepatitis B and C News

Scientists at the Loyola University Chicago Stritch School of Medicine have found that the hepatitis C virus uses the iron-uptake receptor transferrin receptor 1 to infect the body in addition to affecting its expression.

The U.S. Food and Drug Administration recently told biopharmaceutical company Dynavax that more safety data is necessary before the agency can approve its hepatitis B vaccine.

New research from Germany shows a correlation between vitamin d deficiencies and levels of hepatitis b virus replication, specifically seasonal deficiencies and chronic hepatitis b.

A recent American College of Physicians meeting highlighted the increasing pressure that is being put on primary care physicians to treat complex infectious diseases, such as hepatitis C.

The Tennessee Department of Health recommends a U.S. Centers for Disease Control and Prevention online STD testing system that gauges a person's level of risk for hepatitis.

Simeprevir, a protease inhibitor designed to treat genotype 1 chronic hepatitis C in adults with compensated liver disease, has been granted priority review by the Food and Drug Administration.

A new international study suggests that new antiviral therapies to treat hepatitis C could greatly reduce the number of cases of the chronic liver disease worldwide.

A new study conducted by researchers from the University of Cincinnati has found that it is cost-effective to target populations with a higher estimated prevalence of hepatitis C for disease screening.

Individuals with various sexually transmitted diseases now have more options when it comes to finding love online.

A new report released by the U.S. Centers for Disease Control and Prevention includes some sobering statistics about sexually transmitted diseases.

Researchers from Saint Louis University, the University of Missouri and the University of Pittsburgh state that a new discovery may make it possible to cure hepatitis B.

A Boston-based biotech company has announced it will stop work on two promising hepatitis C drugs.

Approximately 150 million people are infected with hepatitis C, a viral infection that negatively impacts the liver, according to the World Health Organization.

One disease that appears to becoming more prominent is hepatitis C, according to the Centers of Disease Control and Prevention (CDC).

As medical experts continue to stress the importance of utilizing protection during intercourse to maintain sexual health, not everyone is up to speed on sexually transmitted diseases (STDs) and how they can negatively impact well-being.

While some people may not think twice about contracting a sexually transmitted disease (STD) before becoming intimate, it's best to know your partner's past prior to engaging in sexual behaviors.

This month, the U.S. Centers for Disease Control and Prevention (CDC) released a new recommendation that baby boomers receive blood tests for hepatitis C.

According to a study funded by the National Cancer Institute and published in the journal Hepatology, the rate of the hepatitis C virus (HCV) in injection drug users (IDUs) was higher in males and African Americans, as compared to other IDUs.

Aging baby boomers appear to be facing health issues at a disproportionate rate, and not just from conditions associated with old age.

A team of scientists at Brown University recently conducted a study which revealed that more than half of high-risk adults are missing out on opportunities to get vaccinated for hepatitis B.